AUTL financials

Autolus Therapeutics (AUTL) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

AUTL income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$75.39M-$20.98M-$270.54M-$287.53M-1.08
2024$10.12M-$1.27M-$241.43M-$220.66M-0.86
2023$1.70M$1.70M-$179.70M-$208.38M-1.20
2022––-$143.41M-$148.84M-1.57
2021––-$141.05M-$142.10M-1.97